Stanley C Erck
CIK 1342826 · President and CEO · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NVAX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
GAITHERSBURG, MD 20878
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MXCT | Director | 428,749 | $1.51 | $647.4K | -$410.6K | 10 | 2026-06-22 |
| NVAX | President and CEO | 36,492 | $9.40 | $343.0K | -$49.70M | 42 | 2022-12-16 |
| BCRX | Director | 48,333 | $7.88 | $380.9K | $48.9K | 12 | 2018-11-30 |
| INTERCELL USA, INC. (IOMI) Delisted | President & CEO | 33,201 | — | — | -$906.2K | 4 | 2008-07-31 |
Recent Filings · Page 2 of 7
70 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-09-28 | NVAX | Mixed | +4,366 | -$41.1K | EDGAR |
| 2022-07-08 | MXCT | Grant (A) | — | $0 | EDGAR |
| 2022-03-14 | NVAX | Grant (A) | — | $0 | EDGAR |
| 2021-12-16 | NVAX | Mixed | +3,601 | -$566.9K | EDGAR |
| 2021-10-05 | NVAX | Mixed | — | -$6.37M | EDGAR |
| 2021-10-05 | NVAX | Mixed | — | -$7.25M | EDGAR |
| 2021-09-28 | NVAX | Mixed | +3,384 | -$784.7K | EDGAR |
| 2021-08-11 | MXCT | Grant (A) | — | $0 | EDGAR |
| 2021-07-06 | NVAX | Mixed | — | -$15.07M | EDGAR |
| 2020-12-16 | NVAX | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.